APA (7th ed.) Citation

Li, S., Hoefnagel, S. J. M., Read, M., Meijer, S., van Berge Henegouwen, M. I., Gisbertz, S. S., . . . Krishnadath, K. K. (2022). Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models. Cellular Oncology (2211-3428), 45(4), 639. https://doi.org/10.1007/s13402-022-00689-2

Chicago Style (17th ed.) Citation

Li, Shulin, et al. "Selective Targeting BMP2 and 4 in SMAD4 Negative Esophageal Adenocarcinoma Inhibits Tumor Growth and Aggressiveness in Preclinical Models." Cellular Oncology (2211-3428) 45, no. 4 (2022): 639. https://doi.org/10.1007/s13402-022-00689-2.

MLA (9th ed.) Citation

Li, Shulin, et al. "Selective Targeting BMP2 and 4 in SMAD4 Negative Esophageal Adenocarcinoma Inhibits Tumor Growth and Aggressiveness in Preclinical Models." Cellular Oncology (2211-3428), vol. 45, no. 4, 2022, p. 639, https://doi.org/10.1007/s13402-022-00689-2.